Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950124-01-001886
Filing Date
2001-04-02
Accepted
2001-04-02 00:00:00
Documents
8
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 k60236e10-k405.htm 10-K405 629974
2 THIRD AMENDMENT TO LEASE k60236ex10-27.htm EX-10.27 13834
3 LEASE EXTENSION k60236ex10-28.htm EX-10.28 3445
4 AMENDMENT TO LICENSE AGREEMENT k60236ex10-29.htm EX-10.29 30504
5 SUBSIDIARIES k60236ex21-1.htm EX-21.1 1362
6 CONSENT OF ARTHUR ANDERSEN LLP k60236ex23-1.htm EX-23.1 1088
7 k60236pi5-178.gif GRAPHIC 1265
8 k60236pi5-110.gif GRAPHIC 1217
  Complete submission text file 0000950124-01-001886.txt   684989
Mailing Address 3621 STATE STREET 695 KMS PLACE ANN ARBOR MI 48108
Business Address 3621 S STATE STREET 695KMS PLACE 734-332-0506 ANN ARBOR MI 48108
ESPERION THERAPEUTICS INC/MI (Filer) CIK: 0001066745 (see all company filings)

EIN.: 383419139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 001-16033 | Film No.: 1588924
SIC: 2834 Pharmaceutical Preparations